BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19666866)

  • 1. Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma.
    Navarro A; Diaz T; Martinez A; Gaya A; Pons A; Gel B; Codony C; Ferrer G; Martinez C; Montserrat E; Monzo M
    Blood; 2009 Oct; 114(14):2945-51. PubMed ID: 19666866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
    Wu H; Huang M; Cao P; Wang T; Shu Y; Liu P
    Cancer Biol Ther; 2012 Mar; 13(5):281-8. PubMed ID: 22310976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of miR-135a on HOXA10 expression, proliferation and apoptosis of ovarian cancer cells].
    Tang WW; Wan GP; Wan YC; Zhang L; Cheng WJ
    Zhonghua Fu Chan Ke Za Zhi; 2013 May; 48(5):364-9. PubMed ID: 24016480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-133b and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling pathway in human renal carcinoma cells.
    Zhou W; Bi X; Gao G; Sun L
    Biomed Pharmacother; 2016 Dec; 84():722-729. PubMed ID: 27710896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo.
    Hao Y; Chapuy B; Monti S; Sun HH; Rodig SJ; Shipp MA
    Clin Cancer Res; 2014 May; 20(10):2674-83. PubMed ID: 24610827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paeoniflorin Alleviates H
    Zhai A; Zhang Z; Kong X
    Neurochem Res; 2019 Dec; 44(12):2821-2831. PubMed ID: 31728857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
    Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
    Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of miR-135a-5p and its target gene JAK2 in spermatozoa of patients with asthenozoospermia.
    Li W; Zhang L; Yin X; Yu T
    Andrologia; 2021 Dec; 53(11):e14214. PubMed ID: 34378214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-135a Regulates Apoptosis Induced by Hydrogen Peroxide in Rat Cardiomyoblast Cells.
    Liu N; Shi YF; Diao HY; Li YX; Cui Y; Song XJ; Tian X; Li TY; Liu B
    Int J Biol Sci; 2017; 13(1):13-21. PubMed ID: 28123342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
    Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
    Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
    Farhadi E; Zaker F; Safa M; Rezvani MR
    Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profiling in classic Hodgkin lymphoma.
    Navarro A; Gaya A; Martinez A; Urbano-Ispizua A; Pons A; Balagué O; Gel B; Abrisqueta P; Lopez-Guillermo A; Artells R; Montserrat E; Monzo M
    Blood; 2008 Mar; 111(5):2825-32. PubMed ID: 18089852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
    Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
    Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
    Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
    Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
    Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.
    Sánchez-Espiridión B; Martín-Moreno AM; Montalbán C; Figueroa V; Vega F; Younes A; Medeiros LJ; Alvés FJ; Canales M; Estévez M; Menarguez J; Sabín P; Ruiz-Marcellán MC; Lopez A; Sánchez-Godoy P; Burgos F; Santonja C; López JL; Piris MA; Garcia JF
    Br J Haematol; 2013 Aug; 162(3):336-47. PubMed ID: 23725219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm.
    Yin LH; Zheng XQ; Li HY; Bi LX; Shi YF; Ye AF; Wu JB; Gao SM
    Leuk Res; 2015 Apr; 39(4):471-8. PubMed ID: 25666256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer.
    Zhou H; Guo W; Zhao Y; Wang Y; Zha R; Ding J; Liang L; Yang G; Chen Z; Ma B; Yin B
    Cancer Sci; 2014 Aug; 105(8):956-65. PubMed ID: 24903309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy.
    Cao Z; Qiu J; Yang G; Liu Y; Luo W; You L; Zheng L; Zhang T
    Cancer Biol Med; 2020 Aug; 17(3):569-582. PubMed ID: 32944391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.